Cranford, NJ, United States of America

Olga Babich

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olga Babich: Innovator in Pain and Diabetes Treatment

Introduction

Olga Babich is a prominent inventor based in Cranford, NJ (US), known for her significant contributions to the field of pharmaceutical sciences. With a focus on sodium channel modulators, she has developed innovative compounds aimed at treating pain and diabetes. Her work has led to the issuance of 2 patents, showcasing her expertise and dedication to advancing medical treatments.

Latest Patents

Olga Babich's latest patents include groundbreaking research on sodium channel modulators for the treatment of pain. These patents detail the development of NaV1.7 modulating compounds, which are designed to alleviate pain through specific pharmaceutical compositions and therapeutic methods. Additionally, she has worked on sodium channel modulators that target both pain and diabetes, further expanding the potential applications of her research.

Career Highlights

Throughout her career, Olga has made significant strides in the pharmaceutical industry. She has been associated with Chromocell Corporation, where she contributed to the development of innovative therapeutic solutions. Her work has not only advanced scientific understanding but has also paved the way for new treatment options for patients suffering from chronic pain and diabetes.

Collaborations

Olga has collaborated with notable professionals in her field, including Robert Zhiyong Luo and David Palling. These partnerships have enhanced her research efforts and contributed to the successful development of her patented compounds.

Conclusion

Olga Babich stands out as a dedicated inventor whose work in sodium channel modulation has the potential to transform the treatment landscape for pain and diabetes. Her innovative spirit and collaborative efforts continue to drive advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…